1. Market Research
  2. > Innocoll, Inc. - Product Pipeline Review - 2013

Innocoll, Inc. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 19 pages

Innocoll, Inc. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Innocoll, Inc. - Product Pipeline Review - 2013” provides data on the Innocoll, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Innocoll, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Innocoll, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Innocoll, Inc. - Brief Innocoll, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Innocoll, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Innocoll, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Innocoll, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Innocoll, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Innocoll, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Innocoll, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Innocoll, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Innocoll, Inc. and identify potential opportunities in those areas.

Table Of Contents

Innocoll, Inc. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Innocoll, Inc. Snapshot 4
Innocoll, Inc. Overview 4
Key Information 4
Key Facts 4
Innocoll, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Innocoll, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Innocoll, Inc. - Pipeline Products Glance 9
Innocoll, Inc. - Late Stage Pipeline 9
Phase III Products/Combination Treatment Modalities 9
Innocoll, Inc. - Drug Profiles 10
bupivacaine hydrochloride Implant 10
Product Description 10
Mechanism of Action 10
RandD Progress 10
gentamicin sulfate 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
gentamicin sulfate Implant 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Innocoll, Inc. - Pipeline Analysis 13
Innocoll, Inc. - Pipeline Products by Therapeutic Class 13
Innocoll, Inc. - Pipeline Products By Target 14
Innocoll, Inc. - Pipeline Products by Route of Administration 15
Innocoll, Inc. - Pipeline Products By Mechanism of Action 16
Innocoll, Inc. - Locations And Subsidiaries 17
Head Office 17
Other Locations and Subsidiaries 17
Appendix 18
Methodology 18
Coverage 18
Secondary Research 18
Primary Research 18
Expert Panel Validation 18
Contact Us 19
Disclaimer 19

List of Tables

Innocoll, Inc., Key Information 4
Innocoll, Inc., Key Facts 4
Innocoll, Inc. - Pipeline by Indication, 2013 6
Innocoll, Inc. - Pipeline by Stage of Development, 2013 7
Innocoll, Inc. - Monotherapy Products in Pipeline, 2013 8
Innocoll, Inc. - Phase III, 2013 9
Innocoll, Inc. - Pipeline By Therapeutic Class, 2013 13
Innocoll, Inc. - Pipeline By Target, 2013 14
Innocoll, Inc. - Pipeline By Route of Administration, 2013 15
Innocoll, Inc. - Pipeline Products By Mechanism of Action, 2013 16
Innocoll, Inc., Subsidiaries 17

List of Figures

Innocoll, Inc. - Pipeline by Indication, 2013 6
Innocoll, Inc. - Pipeline by Stage of Development, 2013 7
Innocoll, Inc. - Monotherapy Products in Pipeline, 2013 8
Innocoll, Inc. - Pipeline By Therapeutic Class, 2013 13
Innocoll, Inc. - Pipeline By Route of Administration, 2013 15
Innocoll, Inc. - Pipeline Products By Mechanism of Action, 2013 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.